NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SymbioMatch

SymbioMatch

Private
CopenhagenHealthcare & Life Scienceshttps://symbiomatch.com/

Last Round

Accelerator

Feb 29, 2024

Total Funding Raised

$1.04M

Company Overview

SymbioMatch is an AgTech company that develops customized biofertilizers using machine learning to identify optimal soil-bacteria-crop combinations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

custom biofertilizerAgTechmachine learning platformbiostimulantsmicrobial inoculantsAI in agriculturesoil data analysisprecision agricultureseed coatingsustainable farmingsoil healthcrop yieldregenerative agriculturechemical fertilizer reductionsoil microbes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SymbioMatch Comparables

Compare SymbioMatch with similar companies based on industry and business-model similarity.

SymbioMatch comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

SymbioMatch Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 29, 2024
GrantDec 31, 2023

Key People

Founding team and executive leadership

Marcela Mendoza Suárez

Chief Executive Officer

Executive Team

SymbioMatch Investors

Notable investors and investment history

SymbioMatch investors
InvestorRounds
Innovation Fund DenmarkGrant
Novo Nordisk FoundationGrant
BioInnovation InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors grew 1069% MoM, from 83 to 970.

  • Dec 31, 2023

    $500K raised from Innovation Fund Denmark and Novo Nordisk Foundation.

SymbioMatch Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SymbioMatch Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SymbioMatch's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range5
Year Founded2024
Last FundingFeb 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.